This information is intended only  for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Vyndaqel® (tafamidis) Great Britain (GB) and Northern Ireland (NI)​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Vyndaqel (tafamidis) - 61mg soft capsules - PI for GB 

Northern Ireland

  • Vyndaqel (tafamidis) - 61mg soft capsules - PI for NI 

Vyndaqel (tafamidis) - 61mg soft capsules - PI for GB 

Vyndaqel (tafamidis) - 61mg soft capsules - PI for NI 

PP-VYN-GBR-0900 October 2021